A review of postural orthostatic tachycardia syndrome
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A 21-year-old female reports an 18-month history of light-headedness on standing. This is often associated with palpitations and a feeling of intense anxiety. She has had two black-outs in the past 12 months. She is not taking any regular medications. Her supine blood pressure was 126/84 mmHg with a heart rate of 76 bpm, and her upright blood pressure was 122/80 mmHg with a heart rate of 114 bpm. A full system examination was otherwise normal. She had a 12-lead electrocardiogram performed which was unremarkable. She was referred for head-up tilt testing. She was symptomatic during the test and lost consciousness at 16 min. Figure 1 summarizes her blood pressure and heart rate response to tilting. A diagnosis of postural orthostatic tachycardia syndrome with overlapping vasovagal syncope was made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines on management (diagnosis and treatment) of syncope
Brignole, M. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2739 · Cited by 951
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., & Lennon, V. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431204 · Cited by 674 · cited 1×
“† Ganglionic acetylcholine receptor antibody is positive in between 10 and 15% of the cases.(4,11) † There is a blunted increase in post-ganglionic sympathetic nerve discharge (muscle sympathetic nerve activity).”
BackgroundOrthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594 · cited 1×
“Genetic A gene mutation encoding the NA transporter protein has been described in patients with POTS phenotype.(18) This protein normally allows reuptake of NA from the synaptic cleft.”
BackgroundIdiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?
Schondorf, R., & Low, P. A. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.132 · Cited by 548
Postural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516
The neuropathic postural tachycardia syndrome
Jacob, G., Costa, F., Shannon, J. R., Robertson, R. M., Wathen, M., Stein, M., Biaggioni, I., Ertl, A., Black, B., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431404 · Cited by 398 · cited 1×
“† It has been shown that the increase in noradrenaline (NA) spillover in the legs is less during orthostasis in POTS patients compared with normal controls.(16) † It has been shown there is excessive leg vein constriction in response to phenylephrine and NA infusion consistent with denervation hypersensitivity.”
BackgroundDi Girolamo, E., Di Iorio, C., Sabatini, P., Leonzio, L., Barbone, C., & Barsotti, A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00694-9 · Cited by 322
Raj, S. R., Biaggioni, I., Yamhure, P. C., Black, B. K., Paranjape, S. Y., Byrne, D. W., & Robertson, D. (2005) · Circulation · doi:10.1161/01.cir.0000160356.97313.5d · Cited by 286 · cited 3×
“Acute treatment with pyridostigmine (30–60 mg) significantly reduced postural symptoms and attenuated the postural tachycardia.(19,57,58) Procholinergic side effects include diarrhoea and excess salivation.”
BackgroundChronic Orthostatic Intolerance: A Disorder With Discordant Cardiac and Vascular Sympathetic Control
Furlan, R., Jacob, G., Snell, M., Robertson, D., Porta, A., Harris, P., & Mosqueda-Garcia, R. (1998) · Circulation · doi:10.1161/01.cir.98.20.2154 · Cited by 229
Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders
Shibao, C., Arzubiaga, C., Roberts, L. J., Raj, S., Black, B., Harris, P., & Biaggioni, I. (2005) · Hypertension · doi:10.1161/01.hyp.0000158259.68614.40 · Cited by 220 · cited 1×
“During one anecdotal study, six patients with POTS and concomitant mast cell activation disorder were contacted following 3 months treatment with anti-histamines and methyldopa, and a subjective clinical improvement in symptoms was documented.(56) These agents may cause drowsiness, dry mouth, or dizziness.”
BackgroundEffects of volume loading and pressor agents in idiopathic orthostatic tachycardia
Jacob, G., Shannon, J. R., Black, B., Biaggioni, I., Mosqueda-Garcia, R., Robertson, R. M., & Robertson, D. (1997) · Circulation · doi:10.1161/01.cir.96.2.575 · Cited by 206 · cited 4×
“Midodrine (5–10 mg) reduced resting and upright heart rate significantly.(43) All these studies looked at acute and not long-term treatment.”
BackgroundInfluentialStewart, J. M. (2000) · Pediatric Research · doi:10.1203/00006450-200008000-00016 · Cited by 198
Postural Tachycardia Syndrome: Clinical Features and Follow-up Study
Sandroni, P., Opfer-Gehrking, T. L., McPhee, B. R., & Low, P. A. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.11.1106 · Cited by 194
Mechanism of ”inappropriate” sinus tachycardia. Role of sympathovagal balance
Morillo, C. A., Klein, G. J., Thakur, R. K., Li, H., Zardini, M., & Yee, R. (1994) · Circulation · doi:10.1161/01.cir.90.2.873 · Cited by 193
Hypocapnia and Cerebral Hypoperfusion in Orthostatic Intolerance
Novak, V., Spies, J. M., Novak, P., McPhee, B. R., Rummans, T. A., & Low, P. A. (1998) · Stroke · doi:10.1161/01.str.29.9.1876 · Cited by 191
Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
Raj, S. R., Black, B. K., Biaggioni, I., Harris, P. A., & Robertson, D. (2005) · Circulation · doi:10.1161/circulationaha.104.497594 · Cited by 171 · cited 1×
“Acute treatment with pyridostigmine (30–60 mg) significantly reduced postural symptoms and attenuated the postural tachycardia.(19,57,58) Procholinergic side effects include diarrhoea and excess salivation.”
BackgroundHypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system
Jacob, G., Robertson, D., Mosqueda-Garcia, R., Ertl, A. C., Robertson, R. M., & Biaggioni, I. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00133-2 · Cited by 164 · cited 1×
“A low renin and aldosterone was found in hypovolaemic patients with orthostatic intolerance and POTS when the opposite would be expected.(19,21)”
BackgroundRadiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping
Man, K. C., Knight, B., Tse, H.-F., Pelosi, F., Michaud, G. F., Flemming, M., Strickberger, S. A., & Morady, F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00546-x · Cited by 142 · cited 1×
“Long-term outcomes have been less favourable.(30,36,37) In patients with overlapping IST and POTS, sinus node ablation does not improve symptoms.”
BackgroundStewart, J. M. (2002) · Circulation · doi:10.1161/01.cir.0000016348.55378.c4 · Cited by 138
Selective Norepinephrine Reuptake Inhibition as a Human Model of Orthostatic Intolerance
Schroeder, C., Tank, J., Boschmann, M., Diedrich, A., Sharma, A. M., Biaggioni, I., Luft, F. C., & Jordan, J. (2002) · Circulation · doi:10.1161/hc0302.102597 · Cited by 127 · cited 1×
“In healthy subjects, these medications reduce tilt-induced syncope or pre-syncope and increase supine blood pressure, but are associated with a significant increase in heart rate pre- and post-tilting.(68,69)”
BackgroundChronic orthostatic intolerance and the postural tachycardia syndrome (POTS)
Stewart, J. M. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.06.084 · Cited by 116 · cited 12×
“It promotes sodium and fluid retention and improves sensitivity of peripheral alpha-adrenergic receptors.49 Fludrocortisone or bisoprolol or both improved the symptoms and haemodynamic abnormalities in a group of 11 patients with POTS.50 Side effects include hypokalaemia, hypomagnesaemia, hypertension, and peripheral…”
BackgroundInfluentialBRADY, P. A., LOW, P. A., & SHEN, W. K. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00227.x · Cited by 98
Masuki, S., Eisenach, J. H., Johnson, C. P., Dietz, N. M., Benrud-Larson, L. M., Schrage, W. G., Curry, T. B., Sandroni, P., Low, P. A., & Joyner, M. J. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00927.2006 · Cited by 91
Blood Volume Perturbations in the Postural Tachycardia Syndrome
Raj, S. R., & Robertson, D. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318063c6c0 · Cited by 80
Freitas, J., Santos, R., Azevedo, E., Costa, O., Carvalho, M., & Falcão de Freitas, A. (2000) · Clinical Autonomic Research · doi:10.1007/bf02281112 · Cited by 78 · cited 12×
“It promotes sodium and fluid retention and improves sensitivity of peripheral alpha-adrenergic receptors.49 Fludrocortisone or bisoprolol or both improved the symptoms and haemodynamic abnormalities in a group of 11 patients with POTS.50 Side effects include hypokalaemia, hypomagnesaemia, hypertension, and peripheral…”
BackgroundInfluentialStewart, J. M., Munoz, J., & Weldon, A. (2002) · Circulation · doi:10.1161/01.cir.0000040999.00692.f3 · Cited by 71
Local vascular responses affecting blood flow in postural tachycardia syndrome
Stewart, J. M., Medow, M. S., & Montgomery, L. D. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00429.2003 · Cited by 71 · cited 1×
“Some authors suggest OH can co-exist with POTS,(40) whereas others do not refer to OH in their definition.(2,41) It is reasonable to exclude significant OH (based on SBP reduction 30 mmHg) particularly when it is prolonged.”
BackgroundSHEN, W., LOW, P. A., JAHANGIR, A., MUNGER, T. M., FRIEDMAN, P. A., OSBORN, M. J., STANTON, M. S., PACKER, D. L., REA, R. F., & HAMMILL, S. C. (2001) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2001.00217.x · Cited by 69
Gordon, V. M., Opfer-Gehrking, T. L., Novak, V., & Low, P. A. (2000) · Clinical Autonomic Research · doi:10.1007/bf02291387 · Cited by 69 · cited 14×
“It promotes sodium and fluid retention and improves sensitivity of peripheral alpha-adrenergic receptors.49 Fludrocortisone or bisoprolol or both improved the symptoms and haemodynamic abnormalities in a group of 11 patients with POTS.50 Side effects include hypokalaemia, hypomagnesaemia, hypertension, and peripheral…”
BackgroundInfluentialTreatment of postural tachycardia syndrome: a comparison of octreotide and midodrine
Hoeldtke, R. D., Bryner, K. D., Hoeldtke, M. E., & Hobbs, G. (2006) · Clinical Autonomic Research · doi:10.1007/s10286-006-0373-0 · Cited by 57 · cited 2×
“9 mcg/kg) suppressed the standing heart rate but did not alter the standing time.(52) Adverse effects include supine hypertension.”
BackgroundStewart, J. M., & Weldon, A. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.4.1505 · Cited by 53
Norepinephrine transporter inhibition prevents tilt-induced pre-syncope
Schroeder, C., Birkenfeld, A. L., Mayer, A. F., Tank, J., Diedrich, A., Luft, F. C., & Jordan, J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.073 · Cited by 45 · cited 1×
“In healthy subjects, these medications reduce tilt-induced syncope or pre-syncope and increase supine blood pressure, but are associated with a significant increase in heart rate pre- and post-tilting.(68,69)”
BackgroundGaffney, F. A. (1983) · CHEST Journal · doi:10.1378/chest.83.2_supplement.436 · Cited by 43
Treatment of orthostatic tachycardia with erythropoietin
Hoeldtke, R. D., Horvath, G. G., & Bryner, K. D. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80230-7 · Cited by 38
Gaffney, F. A., Lane, L. B., Pettinger, W., & Blomqvist, C. G. (1983) · Chest · doi:10.1378/chest.83.2.436 · Cited by 36 · cited 1×
“There was an attenuated increase in standing NA level and total peripheral resistance with treatment.(55) Another study showed that clonidine (single dose of 0.”
BackgroundImpaired baroreflex gain in patients with inappropriate sinus tachycardia
LEON, H., GUZMAN, J. C., KUUSELA, T., DILLENBURG, R., KAMATH, M., & MORILLO, C. A. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2005.04441.x · Cited by 35
Cited by
Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370
Single centre experience of ivabradine in postural orthostatic tachycardia syndrome
McDonald, C., Frith, J., & Newton, J. L. (2011) · Europace · doi:10.1093/europace/euq390 · Cited by 105
Reynolds, G. K., Lewis, D. P., Richardson, A. M., & Lidbury, B. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12161 · Cited by 70
Zhang, F., Li, X., Ochs, T., Chen, L., Liao, Y., Tang, C., Jin, H., & Du, J. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.025 · Cited by 66
Celletti, C., Camerota, F., Castori, M., Censi, F., Gioffrè, L., Calcagnini, G., & Strano, S. (2017) · BioMed Research International · doi:10.1155/2017/9161865 · Cited by 62
“POTS is one of the most common manifestations of OI and is defined as a sustained heart rate (HR) increase of ≥30 bpm or increase of HR to ≥120 bpm usually within the first 10 minutes of orthostasis associated with symptoms of OI but without orthostatic hypotension (OH), which is in turn defined as a drop of >20mmHg i…”
Background
Metadata
- Authors
- Carew, S., Connor, M. O., Cooke, J., Conway, R., Sheehy, C., Costelloe, A., & Lyons, D.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11-12
- Volume
- 11
- Issue
- 1
- Pages
- 18-25
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W1970485922
- Cited by
- 73
- References
- 36
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.